Prostate News and Research

RSS

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

The use of vitamin E and selenium in preventing the recurrence and progression of NMIBC.

19 Oct 2023

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer-; both of which helped patients live longer without their disease progressing than the current standard treatment.

18 Oct 2023

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.

18 Oct 2023

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.

18 Oct 2023

Research suggests a potential new approach for halting the spread of pancreatic cancer

A new study carried out in mice, led by Queen Mary University of London, has identified cells that drive the spread of pancreatic cancer and discovered a weakness in these cells that could be targeted using existing drugs.

18 Oct 2023

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Research published in the Journal of Internal Medicine indicates that SARS-CoV-2 infection may worsen lower urinary tract symptoms (LUTS) in men.

18 Oct 2023

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

Hackensack University Medical Center has established the Center for Weight Loss and Metabolic Health, an integrated program to help people who have struggled to lose weight to achieve and maintain their weight loss goals.

13 Oct 2023

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

11 Oct 2023

Protein antigen from a childhood vaccine can help refocus the body's immune system against cancer

A University of Massachusetts Amherst team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body's immune system against the cancer, effectively halting it and preventing its recurrence.

10 Oct 2023

Study uncovers novel therapeutic target for osteoblastic lesions in prostate cancer bone metastasis

In a study published in the journal Genes & Diseases, researchers from Army Medical University and Shenzhen University investigated the pivotal role of miR-18a-5p, a microRNA, in the development and progression of osteoblastic lesions resulting from prostate cancer (PCa) bone metastasis.

9 Oct 2023

New model for lung cancer screening eligibility more accurate than current USPSTF method

A new study found that an alternative model to identify patients with lung cancer eligible for screening was more accurate than the currently used method based on the United States Preventive Services Task Force (USPSTF) criteria.

9 Oct 2023

Is HPV infection a hidden risk factor for prostate cancer?

In a comprehensive meta-analysis published in Scientific Reports, researchers unveil a significant link between human papillomavirus (HPV) infection and increased risk of prostate cancer, highlighting the importance of considering normal prostate tissues over benign prostatic hyperplasia (BPH) as controls for more accurate conclusions.

8 Oct 2023

Machine learning can simplify lung cancer screening process

Machine learning models to identify the simplest way to screen for lung cancer have been developed by researchers from UCL and the University of Cambridge, bringing personalized screening one step closer.

6 Oct 2023

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases.

6 Oct 2023

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.

3 Oct 2023

Machine learning model can identify who needs lung cancer screening

A machine learning model equipped with only data on people's age, smoking duration and the number of cigarettes smoked per day can predict lung cancer risk and identify who needs lung cancer screening, according to a new study publishing October 3rd in the open access journal PLOS Medicine by Thomas Callender of University College London, UK, and colleagues.

3 Oct 2023

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

3 Oct 2023

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

3 Oct 2023

Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

Patients who have undergone pelvic radiotherapy may live with low-grade chronic inflammation of the lower intestine 20 years after the treatment. 0

29 Sep 2023

Challenges and opportunities for better lung cancer care for the elderly

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 17, entitled, "Promising trends in lung cancer care, but are we overlooking the majority?"

28 Sep 2023

Prostate News and Research

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Research suggests a potential new approach for halting the spread of pancreatic cancer

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Protein antigen from a childhood vaccine can help refocus the body's immune system against cancer

Study uncovers novel therapeutic target for osteoblastic lesions in prostate cancer bone metastasis

New model for lung cancer screening eligibility more accurate than current USPSTF method

Is HPV infection a hidden risk factor for prostate cancer?

Machine learning can simplify lung cancer screening process

Altering certain molecular interactions could yield new strategies for treating prostate cancer

New drugs have increased survival rates for men with metastatic prostate cancer

Machine learning model can identify who needs lung cancer screening

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

Challenges and opportunities for better lung cancer care for the elderly

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News